INCE the concept of MST for treating drug-resistant epileptic foci in eloquent brain cortex was described, 7 a number of experimental studies 4,21 and a series of publications presenting mixed patient series have been published, the majority composed of patients in whom cortical resections or lesionectomies were combined with MST in adjoining cortical areas. 1, 2, 5, 6, 13, 14, [16] [17] [18] 20, 22, 24, 25 Usually the number of cases treated with pure MST in these series were fewer than 10, except in the Smith series, 19 in which 16 patients had partial seizures and MST only, plus a long follow-up period, and a very brief report by Lui, et al., 6 in which there were 50 patients in whom an MR imaging evaluation was not performed. The concept of MST as developed by Morrell and Hanbery, 7 has been summarized by other authors, 8, 19, 20, 22 and needs not be repeated in detail. In brief, its aim is to transect horizontal nerve fibers within the cortex and at the same time preserve the columnar organization of the brain with the vertical fibers undisturbed. The lateral spread and the synchronization of epileptic activity is interrupted, and at the same time most of the vertical input and output to the cortical layers, as well as most of the vascular supply, is preserved. Recently this concept has been applied to epileptiform conditions such as LKS, ESES syndrome, and autistic epileptiform regression. 9, 11, 12, 17, 20 The assessment of efficacy of MST has been hampered by the combination of lesionectomies or corticectomies with MST, and therefore it can be assessed reliably only in pure MST cases. In assessing the 24 cases of pure MST in 103 consecutive patients in whom MST was applied, our aim was to describe the surgical procedure, outcome with regard to seizures, and complications (four of the 24 patients had epileptiform syndromes and were studied solely for their complications, not their outcomes). With 20 pure MST cases with drug-resistant epilepsy that were assessable for seizure outcome, this is the largest series in which MR imaging and sequential follow-up data are available. 
Clinical Material and Methods

Patient Population
Twenty patients with drug-resistant epilepsy with pure MST only and a minimum follow-up duration of 16 months were included in this study. The 20 consecutive patients (13 males and seven females), who had a mean age at operation of 26 Ϯ 10 years (range 7-46 years), were selected from a total of 103 patients with MST, including six with pure MST from an earlier study by Hufnagel, et al. 5 This included three children younger than 18 years of age. The mean age at which epilepsy manifested itself was 10 Ϯ 5 years. Seizure history covered a mean of 16 Ϯ 9 years. The following occurred in various combinations: complex partial seizures and simple partial seizures in 14 patients each, drop attacks in two patients, and generalized seizures in 14 patients. The median postoperative follow-up duration was 58 months (range 16-72 months), the mean follow-up duration was 49.3 Ϯ 18.3 months; 17 patients had a minimum follow-up duration of more than 32 months. One case of progressive Rasmussen encephalitis is included. Indications for surgery included cases in which the epileptogenic area was located in eloquent cortex or extended from the cortex immediately adjoining into the eloquent area, or it was used for a secondary focus in eloquent cortex in two patients in whom a previous two-thirds temporal lobe resection had not led to freedom from seizures. Because the one patient with Rasmussen encephalitis had not transferred all his functions to the other hemisphere, we tried to avoid the new deficits expected to stem from hemispherectomy. Four patients with typical benign focal epilepsies of childhood (LKS in Cases 13 and 22, and ESES syndrome in Cases 14 and 23) are only discussed with regard to surgical procedure and complications. Clinical data and outcomes are summarized in Table 1 .
Clinical Findings
Follow-up visits were required after 3 to 6 months, and then at yearly intervals. The most recent follow-up data were obtained during telephone interviews. Data were obtained from the prospectively kept epilepsy surgery database and checked or completed if necessary by telephone interviews of patients, their relatives, or treating physicians for this review.
Presurgical Evaluation
The presurgical evaluation included continuous video and scalp EEG monitoring, MR imaging, and neuropsychological evaluation in all patients. Positron emission tomography was performed in 18 patients and SPECT in 12 (10 ictal and interictal SPECT scans, and two that were interictal only). Chronic subdural recordings from strip and/or grid electrodes were obtained in 19 patients. These invasive In patients with well-defined structural lesions not located next to functionally critical cortex and with concordant noninvasive ictal video and EEG monitoring, it is often possible to avoid invasive recordings. Intraoperative ECoG recordings can be used to determine the extent of subpial transections, especially if interictal scalp EEG recordings demonstrate localized spiking or if localized spike activity can be elicited by systemic administration of methohexital. In these cases, however, it is often possible to resect at least part of the epileptogenic zone, so that MSTs are only necessary in addition to the resection, if at all. Therefore, chronic rather than acute intraoperative ECoG recordings were obtained in all but one of our patients treated with pure MST.
In one patient with Rasmussen encephalitis, neither chronic recording nor intraoperative ECoG studies were performed. In this patient, MR imaging demonstrated cortical signal enhancement of the right hemisphere, sparing only the occipital lobe. An intracarotid amobarbital test proved that the patient's well-preserved ability to move and use her left hand, arm, and leg was subserved by the right hemisphere. Thus, hemispherectomy was not possible, and MST was chosen as a palliative procedure. Because the symptomatology of her jacksonian motor and sensory seizures clearly allowed us to localize the seizure origin, and it would not have been possible to transect the potentially epileptogenic cortex completely, the pre-and postcentral area of transection was defined only by clinical considerations.
Notably, in six patients instead of cortical resection, pure MST was performed in cortical regions that are normally not considered to be functionally critical. These areas included the right temporoparietal (Cases 3, 19, and 23), the right lateral frontal (Cases 7 and 11), and the right mesial frontal cortex (Case 18). In these patients, invasive recordings indicated localized but widespread (nonlesional) epileptogenicity without clear demarcation. Despite reduced chances of postoperative seizure control, epilepsy surgery was not rejected because of these patients' catastrophic situations, which entailed high rates of severe seizures. Nevertheless, because of the reduced chances of postoperative freedom from seizure, extensive resections of parietal or frontal cortices were judged to be too risky because of possible neuropsychological and/or neuropsychiatric complications, as previously described. 5 Localizing presurgical findings, which were used to guide transections as well as nonconcordant and discordant results are summarized in Table 1 .
Preoperative MR imaging findings were available in all cases. Excluding the four patients with epileptiform syndrome, no pathological findings were detected in 13 patients, a circumscribed lesion was found in six, and an extensive cortical dysplasia in one. The cortical lesions included three suspected hamartias, a gliotic cortical atrophy, a suspected heterotopia, and one case of Rasmussen encephalitis. Biopsy samples from within functionally critical cortex were usually not obtained.
Surgical Procedure
Because most patients (19 of 20) underwent presurgical evaluation with grids or strips of electrodes, trepanations were usually planned to be wide enough to allow for direct access to all relevant brain areas. Occasionally, strips were pushed underneath the bone and if extraoperative ECoG findings indicated MST in areas underneath the bone, craniotomies were expanded. For interhemispheric MST, longer midline craniotomies are used to enable bypassing of bridging veins by using multiple entry corridors. Initially, all operations were performed according to the classic method published by Morrell and Hanbery, 7 in which the bent transector instrument tip points upward toward the pia and the transection is performed perpendicular to the long axis of the gyrus at a distance of 4 to 5 mm, with a wedge-shaped variation around the bend of a gyrus, similar to a recent description by Wyler. 23 Approximately 1 year after Wyler 24 published his modified method, in which the tip of the transecting instrument points downward, we adopted his technique. In a small number of cases, transection lines perpendicular to the long axis of the gyrus were supplemented by a few transection lines perpendicular to the first one, either because spiking did not resolve, or because gyral patterns such as branching or fusing gyri or bends made a simple rectangular pattern of transection cuts difficult or impossible to perform.
Results
We performed MST in the following brain areas, with more than one area transected in some patients: precentral gyrus in 13, postcentral gyrus in 11, Broca area in five, Wernicke area in seven, visual cortex in one, supplementary motor area in seven, cingulate gyrus in one, frontal lobe without Broca or precentral area in two, and temporal lobe without Wernicke area in one (Fig. 1) .
Seizure Outcome
Analysis of seizure outcome was done in the 20 patients and covered a minimum of 1 year and a maximum of 5 years. As shown in Table 2 , according to the Engel 3 classification, at maximum follow-up duration one patient (5%) was Class I (seizure free), one (5%) suffered up to two seizures per year (Class II), and seven (35%) showed more than 75% reduction in their seizure frequency (Class III). Class IV outcome, a less than 75% reduction in seizure frequency, was found in 11 patients (55%).
The Engel classification may not be ideally suited for such a palliative procedure; therefore, applying an alternative classification suggested by S. Spencer (unpublished data) may be more helpful. The grades for the Spencer classification are as follows: excellent, more than 95% reduction of monthly seizure frequency; good, 75 to 95% seizure reduction; fair, 50 to 75% seizure reduction; poor, up to 50% seizure reduction; and worse, more frequent seizures. According to this scale, satisfying results (combined excellent, good, and fair grades) were achieved in 10 cases (50%) in our study.
In an attempt to assess the influence of the size of the MST area, the 20 cases were divided into three groups, those with small (Ͻ 40 cm ) MST areas (see Fig. 1 ) (Cases 4, 7, 9, 11, 16, and 19). If patients are grouped according to the outcome classes, it becomes clear that in the six patients with large MST areas the majority (four of six) were in the unsatisfactory outcome group, which is Engel Class IV, whereas four of seven in the group with small MST areas had satisfactory outcome (Engel Classes I-III). The alternative outcome classification detailed in Table 2 places even more patients in the group with small areas of transection into satisfactory outcome categories (excellent, good, and fair). Regardless of the classification used, it appears that very large MST areas are associated with a poor outcome, albeit without statistical verification.
The presence of a detectable lesion on MR imaging was infrequent and the small number of patients did not allow statistical testing, but it appears that outcome is worse in these cases (Table 3) .
Seizure Outcome Over Time
The change in postoperative seizure results over time showed some interesting dynamics (Fig. 2) . Seizure outcome assessed at five time periods after surgery demonstrated both improvements (six patients) and declines (eight patients) in outcome class. In one patient decline was noted between the 6th and 12th month postoperatively, and the patient returned to the initial outcome class in the next 12 months. Eighty percent of patients stayed in the same outcome class in the first and second evaluation. Between the second and third evaluation, three patients deteriorated and six improved. The outcome class reached at the third time point was maintained for 2 years, but changed during the 5th year in four patients. For the early (6-month) outcome, this meant that in 13 (65%) of 20 cases outcome later changed. Deterioration from Class I occurred in two patients (to Class IV ultimately) and deterioration from Class III to IV occurred in six patients. Improvement was also noted in five patients, however; one went from Class III to II, and four went from Class IV to III.
To summarize the dynamics of these changes, it could be said that the very best initial results tended to become worse; however, an improvement from a relatively poor outcome class to a somewhat better one was possible. Most changes happened during the 6-to 24-month follow-up period. Even initial Class IV outcome improved to Class III in four of eight cases. The results from this group of patients indicate that for any MST group to be judged, detailed follow-up review appears to be necessary.
Complications and Nonseizure Outcome
For a review of complications, four more cases are included (two each with ESES syndrome and LKS). There were seven neurological (29%) and four surgical complications in 10 (42%) of 24 patients. All neurological deficits were temporary in the sense that they ultimately did not result in a deficit that would be noticed during a standard clinical examination. Of these deficits, three had disappeared by the time of discharge, and four resolved in later weeks. There were two dysphasias after left temporal MST, four hemipareses after right central MST, and one leg monoparesis after right central MST. Very mild and hardly noticeable clumsiness with rapidly antagonistic fine finger movements was noticed in several of the patients who underwent MST.
The surgical complications included two that were not specific for MST: one subdural hygroma that needed to be evacuated and one infected bone flap that needed revision and cranioplasty. Two complications were related to the MST procedure itself; these consisted of two cases with remarkable intraoperative brain swelling and edema, one of these with large intracerebral hematoma. In both patients with intraoperative brain swelling the bone flap was left out and duraplasty was performed, followed later by reinsertion of the patient's own bone flap. In one other uneventful case, one 12-to 14-mm and two 8-to 10-mm ICHs were removed during the MST procedure. In the two patients with intraoperative brain swelling no significant permanent deficit was notable on long-term follow-up review, despite the intraoperative complication. The large hematoma was found in the central area on the postoperative control CT scan, and the lesion was evacuated. In the late follow-up review, despite the impressive early postoperative CT scan (Fig. 3) , no significant damage was found, and the patient showed remarkable improvement in his social development, and his seizures diminished to two or fewer per year compared with five per day preoperatively.
In the group with Class IV outcome, four patients had additional surgical interventions: one with Rasmussen encephalitis underwent a functional hemispherectomy and became free of seizures. Two underwent implantation of a va- gal nerve stimulator, resulting in a more than 50% reduction of seizure frequency in one and no improvement in the other. The patient in Case 11 later underwent a frontal lobectomy with no improvement (Fig. 4) .
Discussion
In recent years, there has been an increase in the use of MST, with a few reports presenting relatively high case numbers of MST alone. 6, 19 For an assessment of the efficacy of MST, however, we must look at the subgroups in which pure MST was performed. To be better able to discriminate between the effects of lesionectomy and MST alone, we selected 20 consecutive patients from our total series of 103 who had been treated with MST.
So far, two large series with sufficient follow up have been published: the reports by Smith 19 (32 pure MST cases, of which 16 were patients with epilepsy), and Whisler 22 (13 pure MST cases). Lui, et al., 6 reported on 50 cases but these had a mean of less than 2 years of follow up.
Our patient series is fairly typical, in that in the majority of cases it reflects the classic indications of drug-resistant epilepsy used by most authors. 1, 2, 6, 10, 13, [16] [17] [18] [19] 22 As stated in our first report, 5 we included no more cases of Rasmussen encephalitis 5, 10, 17 or holohemispheric dysplasias, as Lui, et al., 6 seem to have done, without MR imaging evaluation (their report mentioned hemiencephalodysplasia in seven of 50 cases). The outcome classifications used in the literature so far have been vague, with terms such as satisfactory or occasional seizures being used. Most frequently, seizure reduction, calculated as the percentage of preoperative seizures, has been used. 5, 10, [14] [15] [16] Others have used the Engel classification, 13, 22 or have only differentiated between seizure reduction of more or less than 90%, 1 more or less than 50%, 2 or between seizure arrest and satisfactory control. 18 Even when the Engel classification is used, some investigators use a 90% seizure reduction as the criterion for worthwhile improvement for Class III, 22 and others use a 75% criterion for the same category. 5 We have used the Engel 3 classification in this study and in the previous one 5 because it is the most widely used, although it does not reproduce the effects of this palliative operation in enough detail. The Spencer classification (unpublished data) was applied in parallel to avoid the ambiguity associated with the definition of worthwhile for Engel Class III. The Spencer system also has the advantage of including a 50% criterion, which is commonly used in drug trials, and it mentions worsening of postoperative seizures, which is not included in the Engel classification.
Outcome Determinations
Only one patient (5%) was seizure free and one (5%) had no more than two seizures per year, yielding a very good result in 10%. If the Engel Class III outcome is classified as worthwhile, a total worthwhile improvement was achieved in 45%. Using the Spencer classification, excellent and good grades added up to 45%, and if fair outcome is included, 50% of patients had a worthwhile improvement. Several authors reported a much higher rate of freedom from seizure: Whisler found Engel Class I in 11 nonprogressive cases (63%), Shimizu identified Class I in six of seven, and Wyler in two of six. Smith found an Engel Class I outcome in 16 pure MST cases (37.5%), and Patil reported two Class I outcomes in five pure MST cases. 14, 15, 18, 19, 22, 25 Other series are more in line with ours, such as the Yale series, in which no patient was seizure free and there was no patient in Engel Class II, 10 or Sawhney and Pacia, 10,13,17 who found no seizure-free cases among the pure MST ones. One should carefully check the follow-up time because outcome can change considerably. 18 In cases reported by Wyler and colleagues, 23, 25 two seizure-free patients had to be reclassified into the 70 to 90% seizure-reduction group.
Despite the remarkable disparity in seizure outcome between groups reported on by the various authors, several factors have become clear as negative predictors for seizure-free outcome (for example, progressive disease such as Rasmussen or other encephalitis). 5, 8, 10, 17 The size of the MST area, although hardly ever discussed by other authors, was found to be a factor in the present series.
Apparently, caution about the long-term prognosis was justified, because in at least two other series the downgrading of outcome class has been described. 16, 23, 25 Changes in seizure outcome over time were mentioned by these authors; in particular, Rougier, et al., 16 reported that five of six patients deteriorated, mostly between the 6th and 12th months of the follow-up period. This is similar to findings in the present study, in which most changes occurred between the 6th and 24th month of follow up. In no other series has improvement in seizure outcome class been reported, as we observed in our series in 25% of patients. In this series, 35% of patients deteriorated during the follow-up period; the majority of them experienced decline during the first 2 years.
One has to speculate why MST does not work in all cases. From experiments in rats it was concluded that seizures were not completely abolished because the ictal focus could still interact with subcortical areas through preserved vertical fibers. 4 It appears likely also that the lack of adequate transection on the two lateral cortical banks of a gyrus, reaching down into the two adjoining sulci, is responsible. Here the transection cannot be visualized and precise alignment of transection lines is difficult to maintain. In the course of time these residual ictogenic areas may regain enough synchronizing effects to reach the U-shaped fibers again and to induce seizures.
In their original description, Morrell, et al., 8 did not mention that the cortex adjoining the two sulci also should be methodically transected down deep, whereas other authors routinely cut deep, 10,18 and Rougier, et al., 16 even opened the sulcus to get down deeper under direct vision. In our own patients, in addition to the superficial cortex, only the superficial part of the two lateral cortical banks were transected as a rule, because in the early cases when we tried to go down deep more methodically we occasionally encountered resistance from vessels and some bleeding in the depth of the sulcus.
Why the seizure outcome class should improve as late as 3 years postsurgery remains open to speculation. Because it has been proven that no axon sprouting occurs through the old transection scars in the cortex, 21 this could not be an explanation for the improvement in outcome grades. Of course, postoperatively recurring seizures require further medical treatment. Thus, it is likely that changes in medication influence the course of postoperative seizure outcome over time. In our study, postoperative medication was not controlled prospectively and cannot be evaluated statis- tically. In two patients in whom seizure outcome improved between two postoperative evaluations, an additional antiepileptic drug had been introduced (oxcarbazepine in Case 12 and clobazam in Case 14) . Nevertheless, the fact that outcome classes improved in five of seven patients without a substantial change in their antiepileptic medication during the period of improvement indicates that postoperative dynamics produced by MST may have contributed to the development of seizure control.
Postoperative Complications
Several authors have stressed the low morbidity rate associated with this procedure. Neurosurgeons adopting this procedure may feel uneasy at first, but are surprised to see capillary oozing settle down quickly and to note only mild and usually transient postoperative neurological changes. Larger series contain descriptions of ICHs of various sizes, 18 ,22 and we have also seen one larger one, although the majority are asymptomatic, especially the 2-to 3-mm ones. Nevertheless, a symptomatic ICH like the one seen in this series has also been seen by Whisler. 22 Early postoperative CT scans or MR images 19, 20, 23, 25 usually show signs of smaller subarachnoid bleeding or tiny hemorrhages, and occasionally a hemorrhage up to 1 cm large. Evidence from our late postoperative MR images and in other studies also shows transection scars not only as smooth thin defects, but frequently with beadlike extensions that could be the result of necrosis of small cortical areas following venous infarction, but these could also be the result of small hemorrhages. 23 Surgical complications were mentioned with similar frequency by other authors.
14,15,19 Excessive brain swelling not caused by the development of hematoma was seen in one of our cases and has not been described by other authors so far. Major neurological disasters such as a high rate of permanent hemiparesis or significant speech disturbance did not happen in our series and are indeed very rare in other studies.
Initial neurological deterioration (hemiparesis, dysphasia, dysnomia, memory reduction) is very common in a high proportion of cases, 5, 10, 16, 17, 22 from single digits to between 20 and 30%, or even affecting all patients. 10, 17 Obviously, the definition of neurological deterioration is handled quite differently from one study to another. Permanent deficits were reported by Pacia, et al., 13 as disturbed proprioception, and by others as hemiparesis 14, 15, 17, 19, 20, 22 and dysphasia 22 or disturbed diadochokinesis. 5 The definition of a complication in this context relies heavily on the definition of a time point at which an expected transient mild deficit becomes an unexpected neurological complication. For the purpose of this paper we have classified anything that lasted longer than 3 months as a permanent complication. In this sense, there was no permanent neurological deterioration.
In summary, the following picture emerges: initial mild disturbances are very frequent and may even be seen in the majority of cases (sensory disturbances, dysnomia, clumsiness). Extensive brain swelling is a rare event, even in very large MST areas, and significant permanent neurological deficits such as hemiparesis do occur, but rarely. It seems useful to develop a definition of an acceptable neurological transient disturbance for contrast with an unacceptable neurological deficit for further evaluation of MST.
Conclusions
Multiple subpial transection alone provides complete relief from drug-resistant seizures in only a small proportion of cases, but it provides a worthwhile improvement in a satisfyingly high proportion of these hitherto untreatable patients. Worthwhile improvement was achieved in 45% of our cases. This treatment is characteristically associated with a relatively high incidence of transient neurological disturbances, which either resolve completely or subside to a hardly noticeable level. The presence of a lesion on MR images and a very large MST area are negative predictors for good outcome. Early outcome may deteriorate in a considerable proportion of cases during the follow-up period, but improvements also occur in 25% of patients. There was no permanent significant morbidity and no patient died.
